FDA Inspection 1006003 — Rhode Island Blood Center, a Division of New York Blood Center, Inc. Woonsocket Donor Center
The FDA completed an inspection of Rhode Island Blood Center, a Division of New York Blood Center, Inc. Woonsocket Donor Center on March 9, 2017 in Woonsocket, RI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 9, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Woonsocket, RI (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 76 | 21 CFR 606.100(b) | Establish, maintain and follow manufacturing SOPs |